⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001861840

Coyne Christine

Reports to the SEC for 2 companies · DUBLIN 1, L2

Transactions

5

Companies

2

Filings

3

CIK

0001861840

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-01	ITRMIterum Therapeutics plc · Share Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2022-02-04	SCYXSCYNEXIS INCA Award	Chief Commercial Officer	AAward	+43.2K sh	—	—	58,200
2022-02-04	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2021-05-10	SCYXSCYNEXIS INCA Award	Chief Commercial Officer	AAward	+15K sh	—	—	15,000
2021-05-10	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+125K sh	—	—	125,000

Recent filings

3

Accepted (ET)
Jul 34
Coyne Christine0000950170-25-093872
SEC(opens sec.gov)
Feb 84
Coyne Christine0001209191-22-007730
SEC(opens sec.gov)
May 124
Coyne Christine0001209191-21-032231
SEC(opens sec.gov)

Companies

2

Address

C/O 25 NORTH WALL QUAY

DUBLIN 1, L2, D01 H104